PLATINUM PARTNERS
Boston Scientific
Boston Scientific is dedicated to transforming lives through innovative medical solutions that improve the health of patients around the world. Our products and technologies are used to diagnose or treat a wide range of medical conditions. Boston Scientific is the world’s leader in less-invasive devices for gastrointestinal conditions.
Boston Scientific’s Core Values are:
Boston Scientific is dedicated to transforming lives through innovative medical solutions that improve the health of patients around the world. Our products and technologies are used to diagnose or treat a wide range of medical conditions. Boston Scientific is the world’s leader in less-invasive devices for gastrointestinal conditions.
Boston Scientific’s Core Values are:
- Caring – We act with integrity and compassion to support patients, customers, our communities and each other.
- Meaningful Innovation – We foster an environment of creativity to transform new ideas into breakthrough services and solutions that create value for patients, customers and employees.
- High Performance – We strive for high performance to benefit our patients, clinicians and shareholders
- Global Collaboration – We work collaboratively to pursue global opportunities that extend the reach of our medical solutions.
- Diversity – We embrace diversity and value the unique talents, ideas and experiences of our employees.
- Winning Spirit – We adapt to change and act with speed, agility and accountability to further improve patient care.
C.R.Kennedy - Medical Solutions
C.R. Kennedy & Company Pty Ltd (CRK), is Australia's foremost distributor in the Medical, Surveying, Imaging and CCTV industries.
With offices throughout Australia and New Zealand, and head-office and major logistics hub in Melbourne, the company offers superb representation and support across all technologies throughout Australasia.
CRK is a multiple award-winning family owned import / export company founded in 1934. CRK staff commitment, dedication and loyalty is outstanding with many of the 200 plus staff achieving decades of continuous service.
C.R. Kennedy has earned many Sales and Distribution Awards from many brands and industries across our Medical, Survey, Photo Imaging and Surveillance divisions, including five awards since 2009 for Medical Distributor of the Year.
The C.R. Kennedy Medical Division has a very successful history in Endoscopy of over 35 years. They have chosen to partner with leading manufacturers such as FujiFilm, IntroMedic Capsule and Summit Imaging reporting system. With the launch of the New FujiFilm Eluxeo
7000 System, FujiFilm is providing Award-Winning Technology.
C.R. Kennedy Medical Solutions is launching a new line - Accura EndoAccessories which will provide even better solutions to Clinicians.
C.R. Kennedy & Company Pty Ltd (CRK), is Australia's foremost distributor in the Medical, Surveying, Imaging and CCTV industries.
With offices throughout Australia and New Zealand, and head-office and major logistics hub in Melbourne, the company offers superb representation and support across all technologies throughout Australasia.
CRK is a multiple award-winning family owned import / export company founded in 1934. CRK staff commitment, dedication and loyalty is outstanding with many of the 200 plus staff achieving decades of continuous service.
C.R. Kennedy has earned many Sales and Distribution Awards from many brands and industries across our Medical, Survey, Photo Imaging and Surveillance divisions, including five awards since 2009 for Medical Distributor of the Year.
The C.R. Kennedy Medical Division has a very successful history in Endoscopy of over 35 years. They have chosen to partner with leading manufacturers such as FujiFilm, IntroMedic Capsule and Summit Imaging reporting system. With the launch of the New FujiFilm Eluxeo
7000 System, FujiFilm is providing Award-Winning Technology.
C.R. Kennedy Medical Solutions is launching a new line - Accura EndoAccessories which will provide even better solutions to Clinicians.
Pentax Medical
PENTAX Medical is a division of HOYA Group delivering endo-imaging solutions. Established in 1919 in Japan, PENTAX Medical is a globally diversified company with R&D innovation and manufacturing centers in Japan, Europe and the United States.
Through leading-edge optical technologies, PENTAX Medical is providing the most advanced clinically relevant endo-imaging solutions. Together with comprehensive customer service offerings, PENTAX Medical is collaborating with customers worldwide to create long-term partnerships and customer satisfaction.
PENTAX Medical is a division of HOYA Group delivering endo-imaging solutions. Established in 1919 in Japan, PENTAX Medical is a globally diversified company with R&D innovation and manufacturing centers in Japan, Europe and the United States.
Through leading-edge optical technologies, PENTAX Medical is providing the most advanced clinically relevant endo-imaging solutions. Together with comprehensive customer service offerings, PENTAX Medical is collaborating with customers worldwide to create long-term partnerships and customer satisfaction.
GOLD PARTNERS
CK Surgitech
CK Surgitech are suppliers of surgical instruments to the Australian market. Strong specialist collaboration and skilled global manufacturing partners, combine to offer an expansive endoscopy product range. This enables us to supply the Australian medical industry with an extensive range of quality products.
CK Surgitech has successfully obtained a range of unique products. In addition to continuous R&D, the company prides itself on an extremely short product to market cycle.
Since its foundation in 2005, CK Surgitech have been able to expand their product portfolio.
Today we are proud to offer innovative products, in the form of the exclusive, segmented oesophageal stent, and the inventive, anti-reflux stent, through to common high volume accessories.
CK Surgitechs ability to supply a broad range of GI products, makes us one the most comprehensive suppliers in Australia.
To complete our extensive range, CK Surgitech are supported by a team of qualified endoscopy nurses. This enables us to facilitate intuitive and educational interactions with all theatre personnel.
Our beliefs are simple: Quality products, at realistic prices.
CK Surgitech are suppliers of surgical instruments to the Australian market. Strong specialist collaboration and skilled global manufacturing partners, combine to offer an expansive endoscopy product range. This enables us to supply the Australian medical industry with an extensive range of quality products.
CK Surgitech has successfully obtained a range of unique products. In addition to continuous R&D, the company prides itself on an extremely short product to market cycle.
Since its foundation in 2005, CK Surgitech have been able to expand their product portfolio.
Today we are proud to offer innovative products, in the form of the exclusive, segmented oesophageal stent, and the inventive, anti-reflux stent, through to common high volume accessories.
CK Surgitechs ability to supply a broad range of GI products, makes us one the most comprehensive suppliers in Australia.
To complete our extensive range, CK Surgitech are supported by a team of qualified endoscopy nurses. This enables us to facilitate intuitive and educational interactions with all theatre personnel.
Our beliefs are simple: Quality products, at realistic prices.
Device Technologies
For over 25 years, Device Technologies has been pioneering possibility in the Australasian healthcare landscape – seeking out and bringing to market, some of the world’s most advanced healthcare products. From high-quality consumables to advanced theatre equipment and robotics, Device Technologies is Australasia’s largest independent provider of medical solutions and technologies.
Partnering with the world’s most innovative medical companies, we offer a comprehensive range of supplies with client care at the core of our values. Our dedicated team of over 650 highly skilled healthcare specialists and support staff, is committed to providing superior outcomes for healthcare professionals and their patients across the entire healthcare community.
For over 25 years, Device Technologies has been pioneering possibility in the Australasian healthcare landscape – seeking out and bringing to market, some of the world’s most advanced healthcare products. From high-quality consumables to advanced theatre equipment and robotics, Device Technologies is Australasia’s largest independent provider of medical solutions and technologies.
Partnering with the world’s most innovative medical companies, we offer a comprehensive range of supplies with client care at the core of our values. Our dedicated team of over 650 highly skilled healthcare specialists and support staff, is committed to providing superior outcomes for healthcare professionals and their patients across the entire healthcare community.
Medtronic
As a global leader in medical technology, services and solutions, Medtronic improves the health and lives of millions of people each year. We believe our deep clinical, therapeutic and economic expertise can help address the complex challenges — such as rising costs, aging populations, and the burden of chronic disease — faced by families and healthcare systems today. But, we can’t do it alone. That’s why we’re committed to partnering in new ways and developing powerful solutions that deliver better patient outcomes.
Founded in 1949 as a medical repair company, we're now among the world's largest medical technology, services and solutions companies, employing more than 85,000 people worldwide, serving physicians, hospitals and patients in more than 160 countries. Join us in our commitment to take healthcare Further, Together. Learn more at Medtronic.com.au
As a global leader in medical technology, services and solutions, Medtronic improves the health and lives of millions of people each year. We believe our deep clinical, therapeutic and economic expertise can help address the complex challenges — such as rising costs, aging populations, and the burden of chronic disease — faced by families and healthcare systems today. But, we can’t do it alone. That’s why we’re committed to partnering in new ways and developing powerful solutions that deliver better patient outcomes.
Founded in 1949 as a medical repair company, we're now among the world's largest medical technology, services and solutions companies, employing more than 85,000 people worldwide, serving physicians, hospitals and patients in more than 160 countries. Join us in our commitment to take healthcare Further, Together. Learn more at Medtronic.com.au
Olympus
For over 60 years, Olympus endoscopes have played a significant role in the early detection and treatment of disease by providing outstanding image quality, alongside Olympus’ proprietary Narrow Band Imaging (NBI) technology.
Our highly advanced diagnostic imaging platform, EVIS EXERA III is used in multiple specialties, including Gastroenterology, Pulmonology, Urology, Gynaecology, ENT and General Surgery. EVIS EXERA III advances the art of endoscopy with high-resolution imaging to provide better visualisation and enhanced workflows. Olympus also provides a comprehensive range of EndoTherapy devices, all of which are designed from the ground up to work seamlessly with Olympus endoscopes.
Olympus plays a leading role across Australia and New Zealand, delivering first class endoscopic product solutions to customers, combined with unparalleled training, technical support and service. Our Olympus LIVE facilities emulate different real-world settings, such as a surgical operating theatre and microscopy laboratory, creating unique and unparalleled learning environments for healthcare professionals, scientists, maintenance engineers, and consumers alike. The concept provides customers with access to our latest technologies and best-in-class education, such as our Olympus Academy program. Since opening our award winning LIVE facility in Melbourne in 2014 we have introduced similar sites in Auckland New Zealand and Sydney in 2017.
For over 60 years, Olympus endoscopes have played a significant role in the early detection and treatment of disease by providing outstanding image quality, alongside Olympus’ proprietary Narrow Band Imaging (NBI) technology.
Our highly advanced diagnostic imaging platform, EVIS EXERA III is used in multiple specialties, including Gastroenterology, Pulmonology, Urology, Gynaecology, ENT and General Surgery. EVIS EXERA III advances the art of endoscopy with high-resolution imaging to provide better visualisation and enhanced workflows. Olympus also provides a comprehensive range of EndoTherapy devices, all of which are designed from the ground up to work seamlessly with Olympus endoscopes.
Olympus plays a leading role across Australia and New Zealand, delivering first class endoscopic product solutions to customers, combined with unparalleled training, technical support and service. Our Olympus LIVE facilities emulate different real-world settings, such as a surgical operating theatre and microscopy laboratory, creating unique and unparalleled learning environments for healthcare professionals, scientists, maintenance engineers, and consumers alike. The concept provides customers with access to our latest technologies and best-in-class education, such as our Olympus Academy program. Since opening our award winning LIVE facility in Melbourne in 2014 we have introduced similar sites in Auckland New Zealand and Sydney in 2017.
Rymed
Rymed Pty. Ltd. imports and distributes medical equipment for the Australian market. Our mission is to provide high quality products supported by our experienced sales and technical support teams. Our traditional markets include the surgical and endoscopic rooms of the hospital, where we have provided cutting-edge technologies for more than ten years.
We have since endeavoured to expand our technology offering to other areas of the medical trade. Products supported by our team at Rymed include a wide range of medical technologies. We currently offer a complete range of electrosurgical equipment, cryosurgery equipment, water-jet dissector/aspiration systems, flexible endoscopic instruments and clips, Stretta, Secca and LPR monitoring.
Rymed Pty. Ltd. imports and distributes medical equipment for the Australian market. Our mission is to provide high quality products supported by our experienced sales and technical support teams. Our traditional markets include the surgical and endoscopic rooms of the hospital, where we have provided cutting-edge technologies for more than ten years.
We have since endeavoured to expand our technology offering to other areas of the medical trade. Products supported by our team at Rymed include a wide range of medical technologies. We currently offer a complete range of electrosurgical equipment, cryosurgery equipment, water-jet dissector/aspiration systems, flexible endoscopic instruments and clips, Stretta, Secca and LPR monitoring.
SILVER PARTNERS
ConMed
CONMED is a global medical technology company committed to offering our customers the power of choice and convenience through a comprehensive range of cost effective, high quality products and services that are recognised as technological leaders by the specialties they serve. Caregivers worldwide within the Orthopaedic, Sports Medicine, General Surgery, Gynaecology, Gastroenterology and Pulmonology markets have come to value the CONMED brand representing a continued dedication to innovation and ever-present focus on improving clinical outcomes for the patients under their care.
At the Endoskills GI Conference, please be sure to see the CONMED Beamer System. This endoscopic electrosurgical platform combines cutting-edge technology into an intuitive, easy-to-use interface. The versatile design of this system offers multiple endoscopic therapies in a single platform. With built-in intelligence, innovation and an intuitive user interface, the Beamer System allows for quick selection of desired clinical effect whilst delivering consistent and repeatable clinical results for multiple therapies from a single platform.
We invite you to visit our booth to learn more about what CONMED can do for you.
CONMED is a global medical technology company committed to offering our customers the power of choice and convenience through a comprehensive range of cost effective, high quality products and services that are recognised as technological leaders by the specialties they serve. Caregivers worldwide within the Orthopaedic, Sports Medicine, General Surgery, Gynaecology, Gastroenterology and Pulmonology markets have come to value the CONMED brand representing a continued dedication to innovation and ever-present focus on improving clinical outcomes for the patients under their care.
At the Endoskills GI Conference, please be sure to see the CONMED Beamer System. This endoscopic electrosurgical platform combines cutting-edge technology into an intuitive, easy-to-use interface. The versatile design of this system offers multiple endoscopic therapies in a single platform. With built-in intelligence, innovation and an intuitive user interface, the Beamer System allows for quick selection of desired clinical effect whilst delivering consistent and repeatable clinical results for multiple therapies from a single platform.
We invite you to visit our booth to learn more about what CONMED can do for you.
Cook Medical
Since 1963, Cook Medical has worked closely with physicians to develop technologies that eliminate the need for open surgery. For the past 35 years, the company’s Endoscopy division has applied that same pioneering, minimally invasive approach to gastroenterology. Today, the division is a worldwide leader in the design, development and manufacture of non-invasive devices used in gastrointestinal endoscopy and bronchoscopy to diagnose and treat esophageal, stomach, pancreatic, liver and colonic disorders.
Participating in all global markets, the division has a simple core mission: Anticipating our customers’ needs and creating prompt, innovative solutions to those needs. We focus our expertise - and the expertise of the world’s leading gastroenterologists - on developing efficient and economical solutions to critical clinical problems. That way, we can help patients live better lives by offering you the most comprehensive selection of endoscopic devices available anywhere. And, every Endoscopy division product is manufactured with the highest quality standards and designed to significantly reduce procedure times, and consequently, overall healthcare costs.
For more information about the Cook Medical Endoscopy division and its products, visit www.cookmedical.com/endoscopy.
Since 1963, Cook Medical has worked closely with physicians to develop technologies that eliminate the need for open surgery. For the past 35 years, the company’s Endoscopy division has applied that same pioneering, minimally invasive approach to gastroenterology. Today, the division is a worldwide leader in the design, development and manufacture of non-invasive devices used in gastrointestinal endoscopy and bronchoscopy to diagnose and treat esophageal, stomach, pancreatic, liver and colonic disorders.
Participating in all global markets, the division has a simple core mission: Anticipating our customers’ needs and creating prompt, innovative solutions to those needs. We focus our expertise - and the expertise of the world’s leading gastroenterologists - on developing efficient and economical solutions to critical clinical problems. That way, we can help patients live better lives by offering you the most comprehensive selection of endoscopic devices available anywhere. And, every Endoscopy division product is manufactured with the highest quality standards and designed to significantly reduce procedure times, and consequently, overall healthcare costs.
For more information about the Cook Medical Endoscopy division and its products, visit www.cookmedical.com/endoscopy.
Ferring
Ferring Pharmaceuticals is a biopharmaceutical company dedicated to the development of innovative treatments in the areas of Gastroenterology, Reproductive Health, Urology/Oncology, Endocrinology and Orthopaedics. Ferring headquarters operates from Saint-Prex, Switzerland and its products are available in 110 countries.
http://www.ferring.com/en/about-ferring/ (link to Ferring Corporate video)
In Australia, Ferring Pharmaceuticals markets PENTASA® (mesalazine) and CORTIMENT® (oral budesonide) indicated for the treatment of Inflammatory Bowel Disease (IBD), PICOSALAX® (sodium picosulfate/magnesium citrate), KLYX® (docusate sodium/sorbitol), Fleet® enema and Phospho®-soda (sodium phosphate monobasic & dibasic) for bowel cleansing, and GLYPRESSIN® Solution (terlipressin) indicated for the treatment of bleeding oesophageal varices (BOV) and hepatorenal syndrome (HRS).
Tel: 61 2 9497 2300
Email: enquiries@ferring.com
Free phone: 1800 33 77 46
Website: www.ferring.com.au
Ferring Pharmaceuticals is a biopharmaceutical company dedicated to the development of innovative treatments in the areas of Gastroenterology, Reproductive Health, Urology/Oncology, Endocrinology and Orthopaedics. Ferring headquarters operates from Saint-Prex, Switzerland and its products are available in 110 countries.
http://www.ferring.com/en/about-ferring/ (link to Ferring Corporate video)
In Australia, Ferring Pharmaceuticals markets PENTASA® (mesalazine) and CORTIMENT® (oral budesonide) indicated for the treatment of Inflammatory Bowel Disease (IBD), PICOSALAX® (sodium picosulfate/magnesium citrate), KLYX® (docusate sodium/sorbitol), Fleet® enema and Phospho®-soda (sodium phosphate monobasic & dibasic) for bowel cleansing, and GLYPRESSIN® Solution (terlipressin) indicated for the treatment of bleeding oesophageal varices (BOV) and hepatorenal syndrome (HRS).
Tel: 61 2 9497 2300
Email: enquiries@ferring.com
Free phone: 1800 33 77 46
Website: www.ferring.com.au
Vifor Pharma
Vifor Pharma is a world leader in iron preparations for the treatment of iron deficiency. The iron portfolio includes Ferinject®, an innovative intravenous iron replacement therapy, Venofer®, the leading intravenous iron product for the treatment of iron deficiency as well as the well-established oral iron, Maltofer®.
Vifor Pharma is a world leader in iron preparations for the treatment of iron deficiency. The iron portfolio includes Ferinject®, an innovative intravenous iron replacement therapy, Venofer®, the leading intravenous iron product for the treatment of iron deficiency as well as the well-established oral iron, Maltofer®.
Medrobotics
Medrobotics manufactures and markets the Flex® Robotic System, the world’s first endoluminal robotic platform with a steerable and shapeable robotic scope. The Flex® Robotic System offers clinicians the unique ability to navigate complex anatomy with crystal clear 3D HD visualization through a single entry point. Once the target disease is accessed, the Flex® Robotic System provides a stable platform through which articulating flexible instruments are introduced providing consistent triangulation in hard-to-reach anatomical locations that might otherwise be inaccessible with traditional surgical instruments and difficult to treat with current endoscopic instruments. The company’s vision is to provide more patients with access to endoluminal treatment options. Medrobotics received FDA clearances for the Flex® Robotic System for ENT applications in July 2015 and for transanal applications in May 2017. The CE mark was issued in March 2014.
Medrobotics manufactures and markets the Flex® Robotic System, the world’s first endoluminal robotic platform with a steerable and shapeable robotic scope. The Flex® Robotic System offers clinicians the unique ability to navigate complex anatomy with crystal clear 3D HD visualization through a single entry point. Once the target disease is accessed, the Flex® Robotic System provides a stable platform through which articulating flexible instruments are introduced providing consistent triangulation in hard-to-reach anatomical locations that might otherwise be inaccessible with traditional surgical instruments and difficult to treat with current endoscopic instruments. The company’s vision is to provide more patients with access to endoluminal treatment options. Medrobotics received FDA clearances for the Flex® Robotic System for ENT applications in July 2015 and for transanal applications in May 2017. The CE mark was issued in March 2014.
Norgine
Norgine markets products designed to optimise bowel cleanliness and improve the detection of adenomas during colonoscopy:
NEW - PLENVU® is a 1 litre macrogol-based bowel preparation, offering patients low total
volume to consume but with the same efficacy and safety of a higher volume macrogol-based bowel preparation.1 PLENVU® offers variety for patients with each dose being a different flavour1 (Mango and Fruit Punch).
MOVIPREP® is a 2 litre macrogol-based bowel preparation that provides efficacy and safety
with patient acceptability.2
ENDOCUFF VISION® is a clinically trialled device fitted to colonoscopes, which improves ADR via improved visibility and tip control during colonoscopy.3
XIFAXAN® 550 mg indicated for prevention of the recurrence of hepatic encephalopathy where other treatments have failed or are contraindicated.4
1. Bisschops R et al. P0179 United European Gastroenterology Journal. 2016 May 11;4(5S):A218–9.
2. MOVIPREP® Product Information-June 2015
3. Ngu WS, et al. Gut 2018;66:1–9.
4. XIFAXAN® 550 mg Product Information-August 2017
Norgine markets products designed to optimise bowel cleanliness and improve the detection of adenomas during colonoscopy:
NEW - PLENVU® is a 1 litre macrogol-based bowel preparation, offering patients low total
volume to consume but with the same efficacy and safety of a higher volume macrogol-based bowel preparation.1 PLENVU® offers variety for patients with each dose being a different flavour1 (Mango and Fruit Punch).
MOVIPREP® is a 2 litre macrogol-based bowel preparation that provides efficacy and safety
with patient acceptability.2
ENDOCUFF VISION® is a clinically trialled device fitted to colonoscopes, which improves ADR via improved visibility and tip control during colonoscopy.3
XIFAXAN® 550 mg indicated for prevention of the recurrence of hepatic encephalopathy where other treatments have failed or are contraindicated.4
1. Bisschops R et al. P0179 United European Gastroenterology Journal. 2016 May 11;4(5S):A218–9.
2. MOVIPREP® Product Information-June 2015
3. Ngu WS, et al. Gut 2018;66:1–9.
4. XIFAXAN® 550 mg Product Information-August 2017
Shire
At Shire, we enable people with life-altering conditions to lead better lives. We focus on developing and delivering innovative medicines for patients with rare diseases and other specialty conditions. This might be a therapy to treat an extremely rare and life-threatening disease such as Gaucher disease or Fabry disease, or a medicine for a specialist condition such as ADHD or ulcerative colitis.
To realize our aspiration to become a leading global biotech, our efforts are concentrated on four key strategic drivers: growth, innovation, efficiency, and people. Our priorities are to drive optimal performance of our existing products, increase patient access to these medicines, and to build our pipeline through research and development and partnerships in order to deliver new medicines to patients.
At Shire, we enable people with life-altering conditions to lead better lives. We focus on developing and delivering innovative medicines for patients with rare diseases and other specialty conditions. This might be a therapy to treat an extremely rare and life-threatening disease such as Gaucher disease or Fabry disease, or a medicine for a specialist condition such as ADHD or ulcerative colitis.
To realize our aspiration to become a leading global biotech, our efforts are concentrated on four key strategic drivers: growth, innovation, efficiency, and people. Our priorities are to drive optimal performance of our existing products, increase patient access to these medicines, and to build our pipeline through research and development and partnerships in order to deliver new medicines to patients.
Takeda
Takeda Pharmaceutical Company Limited is a global research and development-driven pharmaceutical company committed to bringing better health and a brighter future to patients by translating science into life-changing medicines. Takeda focuses its R&D efforts on oncology, gastroenterology and central nervous system therapeutic areas plus vaccines. Takeda conducts R&D both internally and with partners to stay at the leading edge of innovation. We aspire to develop new and innovative products, with a focus on oncology and gastroenterology, to fuel the growth of Takeda . More than 30,000 Takeda employees are committed to improving quality of life for patients, working with our partners in health care in more than 70 countries.
Takeda Pharmaceutical Company Limited is a global research and development-driven pharmaceutical company committed to bringing better health and a brighter future to patients by translating science into life-changing medicines. Takeda focuses its R&D efforts on oncology, gastroenterology and central nervous system therapeutic areas plus vaccines. Takeda conducts R&D both internally and with partners to stay at the leading edge of innovation. We aspire to develop new and innovative products, with a focus on oncology and gastroenterology, to fuel the growth of Takeda . More than 30,000 Takeda employees are committed to improving quality of life for patients, working with our partners in health care in more than 70 countries.
Vitramed
Operating in Oceania and South East Asia, Vitramed specialises in the area of gastrointestinal medical devices, accessories and supplements.
Just like you, our team is primarily focused on the area of gastrointestinal medicine. This focus allows us to best help you access the best tools available, for the benefit of your patients and your operation.
Our goal is to continue to bring you unique and reliable devices that utilise the latest technology and then provide ongoing support to ensure they add value to your clinical practice.
Operating in Oceania and South East Asia, Vitramed specialises in the area of gastrointestinal medical devices, accessories and supplements.
Just like you, our team is primarily focused on the area of gastrointestinal medicine. This focus allows us to best help you access the best tools available, for the benefit of your patients and your operation.
Our goal is to continue to bring you unique and reliable devices that utilise the latest technology and then provide ongoing support to ensure they add value to your clinical practice.